Article
Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus.
Cancer gene therapy - 1 Nov 2000
Frizelle S P, Rubins J B, Zhou J X, Curiel D T, Kratzke R A
Abstract excerpt
The absence of expression of the p16INK4a gene product is observed in virtually all mesothelioma tumors and cell lines, whereas wild-type pRB expression is maintained. We have examined the potential therapeutic role of re-expressing the p16INK4a gene product in mice with established human mesothelioma xenografts. Experiments using Adp16 treatments in mesothelioma xenografts demonstrated prolonged survival and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
